$BIOX Balance Sheet | Understand Stock

$BIOX

$0.24 +$0.03 (16.95%) Close

$BIOX Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated statements of financial position

In millions of USD, except per-share amounts

	Q4 FY2025 As of Jun 30, 2025	Q4 FY2024 As of Jun 30, 2024	Q4 FY2023 As of Jun 30, 2023	Q4 FY2022 As of Jun 30, 2022	Q4 FY2021 As of Jun 30, 2021	Q4 FY2020 As of Jun 30, 2020	Q4 FY2019 As of Jun 30, 2019
Cash and cash equivalents
Accounts receivable
Inventories
Prepaid expenses and other current assets
Total current assets
Property, plant and equipment, net
Right of use assets, net
Intangible assets, net
Goodwill
Restricted cash
Other assets
Total assets
Accounts payable
Accrued liabilities
Deferred revenue, current portion
Lease liability, current portion
Debt, current portion, net
Total current liabilities
Deferred revenue, less current portion
Lease liability, less current portion
Debt, less current portion, net
Other liabilities
Total liabilities
Common stock: $0.00001 par value; 250,000 shares authorized, 182,624 and 182,224 shares issued and outstanding as of June 30, 2022 and December 31, 2021, respectively
Additional paid in capital
Accumulated deficit
Total stockholders' equity
Total liabilities and stockholders' equity
ASSETS
Current
Cash and cash equivalents
Other financial assets
Trade receivables
Other receivables
Recoverable income tax
Inventories
Biological assets
Total current assets
NON-CURRENT ASSETS
Other financial assets
Trade receivables
Other receivables
Recoverable income tax
Deferred tax assets
Investments in joint ventures and associates
Investment properties
Property, plant and equipment
Intangible assets
Goodwill
Right of use asset
Total non-current assets
Total assets
LIABILITIES
CURRENT LIABILITIES
Trade and other payables
Borrowings
Employee benefits and social security
Deferred revenue and advances from customers
Income tax payable
Government grants
Financed payment - Acquisition of business
Consideration for acquisition
Secured notes
Lease liabilities
Total current liabilities

NON-CURRENT LIABILITIES
Trade and other payables
Borrowings
Employee benefits and social security
Deferred revenue and advances from customers
Government grants
Joint ventures and associates
Deferred tax liabilities
Provisions
Consideration for acquisition
Private warrants
Secured notes
Lease liabilities
Total non-current liabilities

Total liabilities
EQUITY
Equity attributable to owners of the parent
Non-controlling interest
Total equity
Total equity and liabilities

Comments